Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/139932
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Salas-Salas, Barbara Gabriela | en_US |
dc.contributor.author | Ferrera Alayón, Laura | en_US |
dc.contributor.author | Calleja-Fernandez, Alicia | en_US |
dc.contributor.author | Chicas-Sett, Rodolfo | en_US |
dc.contributor.author | Nogues-Ramia, Eva | en_US |
dc.contributor.author | Zafra-Martin, Juan | en_US |
dc.contributor.author | Lloret Sáez-Bravo, Marta | en_US |
dc.date.accessioned | 2025-06-11T08:14:08Z | - |
dc.date.available | 2025-06-11T08:14:08Z | - |
dc.date.issued | 2024 | en_US |
dc.identifier.issn | 2296-861X | en_US |
dc.identifier.other | WoS | - |
dc.identifier.other | Scopus | - |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/139932 | - |
dc.description.abstract | Background: Patients with rectal cancer may develop gastrointestinal toxicity associated with chemo-radiotherapeutic treatment that conditions their clinical, functional, and nutritional evolution. The aim of the study was to evaluate the efficacy of nutritional supplementation with a glutamine-enriched peptide diet (PD) compared to exclusive dietary advice (DA) on gastrointestinal toxicity, interruption of oncologic treatment, and nutritional evolution in patients with rectal cancer undergoing neoadjuvant treatment.Methods Prospective cohort study with two groups. Patients with rectal cancer in treatment with neoadjuvant chemo-radiotherapy were recruited. One group of patients received nutritional supplementation with PD, and another group received DA exclusively, from the beginning of radiotherapy until the time of surgery. Intestinal toxicity was evaluated with the CTCAE 5.0 scale, functionality with the ECOG scale and nutritional status with GLIM criteria.Results Fifty-four patients were initially selected, although 51 were finally enrolled: 25 in the PD group and 26 in the DA group. There was a reduction in the risk of diarrhea in the PD group midway through radiotherapy treatment [RR of 0.218 (95% CI = 0.052-0.923)] and at the end of treatment [RR of 0.103 (95% CI = 0.020-0.537)], as well as a reduction in the risk of developing mucositis at the end of treatment [RR of 0.405 (95% CI = 0.280-0.584)]. The use of a PD also decreased treatment interruptions with radiotherapy in stage III patients (0 vs. 15.8%, p = 0.049) and in malnourished patients (0 vs. 18.2%, p = 0.040).Conclusion The glutamine-enriched peptide diet had a protective effect on the development of diarrhea and mucositis associated with chemo-radiotherapeutic treatment in patients with colorectal cancer under neoadjuvant treatment, as well as the interruption of radiotherapeutic treatment. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Frontiers In Nutrition | en_US |
dc.source | Frontiers In Nutrition [ISSN 2296-861X], v. 11, (Diciembre 2024) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320101 Oncología | en_US |
dc.subject | 3208 Farmacodinámica | en_US |
dc.subject.other | Induced Oral Mucositis | en_US |
dc.subject.other | Elemental Diet | en_US |
dc.subject.other | Radiation Enteritis | en_US |
dc.subject.other | Colorectal-Cancer | en_US |
dc.subject.other | Chemotherapy | en_US |
dc.subject.other | Nutrition | en_US |
dc.subject.other | Efficacy | en_US |
dc.subject.other | Acid | en_US |
dc.subject.other | Chemoradiotherapy | en_US |
dc.subject.other | Metaanalysis | en_US |
dc.subject.other | Peptide Diet | en_US |
dc.subject.other | Oral Nutritional Supplement | en_US |
dc.subject.other | Radiotherapy | en_US |
dc.subject.other | Rectal Cancer | en_US |
dc.subject.other | Glutamine | en_US |
dc.title | Impact of a glutamine-enriched peptide formula on gastrointestinal toxicity and on the interruption of oncologic treatment in patients with adenocarcinoma of the rectum | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3389/fnut.2024.1414367 | en_US |
dc.identifier.scopus | 85214024667 | - |
dc.identifier.isi | 001388790000001 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.authorscopusid | 57209142019 | - |
dc.contributor.authorscopusid | 57209144026 | - |
dc.contributor.authorscopusid | 35110995800 | - |
dc.contributor.authorscopusid | 57190872784 | - |
dc.contributor.authorscopusid | 57217064444 | - |
dc.contributor.authorscopusid | 57208737651 | - |
dc.contributor.authorscopusid | 7003855087 | - |
dc.identifier.eissn | 2296-861X | - |
dc.relation.volume | 11 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 67080984 | - |
dc.contributor.daisngid | 20889526 | - |
dc.contributor.daisngid | 50140879 | - |
dc.contributor.daisngid | 959685 | - |
dc.contributor.daisngid | 26358519 | - |
dc.contributor.daisngid | 2490050 | - |
dc.contributor.daisngid | 10747011 | - |
dc.description.numberofpages | 10 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Salas-Salas, BG | - |
dc.contributor.wosstandard | WOS:Ferrera-Alayón, L | - |
dc.contributor.wosstandard | WOS:Calleja-Fernández, A | - |
dc.contributor.wosstandard | WOS:Chicas-Sett, R | - |
dc.contributor.wosstandard | WOS:Nogués-Ramia, E | - |
dc.contributor.wosstandard | WOS:Zafra-Martín, J | - |
dc.contributor.wosstandard | WOS:Lloret, M | - |
dc.date.coverdate | Diciembre 2024 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 0,828 | |
dc.description.jcr | 4,0 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q2 | |
dc.description.esci | ESCI | |
dc.description.miaricds | 8,3 | |
item.grantfulltext | open | - |
item.fulltext | Con texto completo | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.fullName | Ferrera Alayón, Laura | - |
crisitem.author.fullName | Lloret Sáez-Bravo, Marta | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.